Edurant and Dolutegravir drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Edurant (rilpivirine hydrochloride) and Dolutegravir (dolutegravir). Common drug interactions include drug ineffective among females and anhedonia among males.
The phase IV clinical study analyzes what interactions people have when they take Edurant and Dolutegravir. It is created by eHealthMe based on reports of 152 people who take the same drugs from the FDA, and is updated regularly.
What is Edurant?
Edurant has active ingredients of rilpivirine hydrochloride. eHealthMe is studying from 2,238 Edurant users. Check the latest studies of Edurant.
What is Dolutegravir?
Dolutegravir has active ingredients of dolutegravir. eHealthMe is studying from 7,071 Dolutegravir users. Check the latest studies of Dolutegravir.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
152 people who take Edurant and Dolutegravir together, and have interactions are studied.
What are the common drug interactions of Edurant and Dolutegravir, by gender? *
What are the common drug interactions of Edurant and Dolutegravir, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Edurant and Dolutegravir?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Edurant (2,238 reports)
- Dolutegravir (7,071 reports)
Browse all drug interactions of Edurant and Dolutegravir:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Edurant:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Dolutegravir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Edurant and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dolutegravir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on rilpivirine hydrochloride and dolutegravir (the active ingredients of Edurant and Dolutegravir, respectively), and Edurant and Dolutegravir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Robitussin cause Lip Swelling? - 2 seconds ago
- Diabetic Ketoacidosis and drugs of ingredients of insulin aspart protamine recombinant; insulin aspart recombinant - 2 seconds ago
- Zelnorm and Intestinal Obstruction for Women aged 60+ - 4 seconds ago
- Anhedonia and drugs of ingredients of phentermine resin complex - 4 seconds ago
- Zelnorm and Pseudo-Obstruction - Intestinal for Women aged 60+ - 4 seconds ago
- Zelnorm and Paralytic Ileus for Women aged 60+ - 5 seconds ago
- Zelnorm and Ileus for Women aged 60+ - 5 seconds ago
- Zelnorm and Bowel Obstruction for Women aged 60+ - 5 seconds ago
- Zelnorm and Intestinal Volvulus for Women aged 60+ - 5 seconds ago
- Conduction Disorder and drugs of ingredients of insulin glargine recombinant - 7 seconds ago